Xeris Pharmaceuticals, Inc. drugs
3 results
Gvoke hypopen (glucagon injection, solution)
(glucagon injection, solution)Xeris Pharmaceuticals, Inc.
Usage: GVOKE is indicated for the treatment of severe hypoglycemia in adults and pediatric patients aged 2 years and older with diabetes. Additionally, GVOKE VialDx is used intravenously as a diagnostic aid to temporarily inhibit gastrointestinal movement during radiologic examinations in adult patients.
Keveyis (dichlorphenamide)
(Dichlorphenamide)Xeris Pharmaceuticals, Inc.
Usage: KEVEYIS is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.
Recorlev (levoketoconazole)
(Levoketoconazole)Xeris Pharmaceuticals, Inc.
Usage: RECORLEV is indicated for treating endogenous hypercortisolemia in adult patients with Cushing's syndrome when surgery is not an option or has not been curative. It is not approved for fungal infections, and its safety and effectiveness for such uses are not established.